Older adults are being warned against receiving the chikungunya vaccine before traveling. The Ixchiq vaccination, developed ...

The FDA and CDC recommended a pause for Ixchiq, a chikungunya vaccine, following reports of adverse events in recipients 60 ...

The Trump administration's FDA and CDC is advising U.S. patients using the drug Ixchiq to hold off while U.S. health ...

Centres for Disease Control and Prevention (CDC) has issued an advisory urging American travellers over the age of 60 years ...

Hold off on inoculating people ages 60 and older against chikungunya infection with the Ixchiq vaccine, the FDA and CDC ...

Chikungunya is transmitted to humans through the bite of infected female mosquitoes, particularly Aedes aegypti and Aedes ...

TUESDAY, May 13, 2025 (HealthDay News) — U.S. health officials are telling travelers aged 60 and older to avoid a chikungunya ...

The US Centers for Disease Control and Prevention (CDC) is warning people planning to travel to the Region of the Indian ...

FDA and CDC recommend halting Ixchiq vaccine use in adults 60 and older after reports of serious adverse events, including ...

On the heels of similar moves in France and the European Union, U.S. health authorities are calling for a pause in the use of ...

The U.S. government is advising that international travelers age 60 and older not get a chikungunya vaccine as it ...

Reports of severe adverse events in some people who received the chikungunya vaccine have spurred regulators in Europe and ...